Literature DB >> 4808917

Chemotherapy of thyroid cancer with adriamycin. Experience with 30 patients.

J A Gottlieb, C S Hill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4808917     DOI： 10.1056/NEJM197401242900404

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  51 in total

Review 1.  Treatment strategies for radioactive iodine-refractory differentiated thyroid cancer.

Authors:  Francis Worden
Journal:  Ther Adv Med Oncol       Date:  2014-11       Impact factor: 8.168

2.  Inhibition of the Ras/Raf/MEK/ERK and RET kinase pathways with the combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in medullary and differentiated thyroid malignancies.

Authors:  David S Hong; Maria E Cabanillas; Jennifer Wheler; Aung Naing; Apostolia M Tsimberidou; Lei Ye; Naifa L Busaidy; Steven G Waguespack; Mike Hernandez; Adel K El Naggar; Alder K El Naggar; Savita Bidyasar; John Wright; Steven I Sherman; Razelle Kurzrock
Journal:  J Clin Endocrinol Metab       Date:  2011-02-02       Impact factor: 5.958

3.  Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer.

Authors:  P De Besi; B Busnardo; S Toso; M E Girelli; D Nacamulli; N Simioni; D Casara; P Zorat; M V Fiorentino
Journal:  J Endocrinol Invest       Date:  1991-06       Impact factor: 4.256

4.  GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma.

Authors:  Jean-Philippe Spano; Y Vano; S Vignot; T De La Motte Rouge; L Hassani; R Mouawad; F Menegaux; D Khayat; L Leenhardt
Journal:  Med Oncol       Date:  2011-09-25       Impact factor: 3.064

5.  Combination chemotherapy of advanced medullary and differentiated thyroid cancer. Phase II study.

Authors:  H Scherübl; F Raue; R Ziegler
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

6.  Progress in Endocrine Neoplasia.

Authors:  Samuel A Wells
Journal:  Clin Cancer Res       Date:  2016-10-15       Impact factor: 12.531

Review 7.  Management of carcinoma of the thyroid.

Authors:  M A Block
Journal:  Ann Surg       Date:  1977-02       Impact factor: 12.969

8.  Molecular and other novel advances in treatment of metastatic epithelial and medullary thyroid cancers.

Authors:  David Tai; Donald Poon
Journal:  J Oncol       Date:  2010-08-24       Impact factor: 4.375

9.  Follicular carcinoma of the thyroid with metastasis to the breast.

Authors:  R C Chisholm; E B Chung; W Tuckson; T Khan; J E White
Journal:  J Natl Med Assoc       Date:  1980-11       Impact factor: 1.798

Review 10.  Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer.

Authors:  Sujata Narayanan; A Dimitrios Colevas
Journal:  Curr Treat Options Oncol       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.